Cat# : THP-0292
| Catalog# | Product Name | Availability | Size | Price | Qty |
|---|---|---|---|---|---|
| THP-0292 | Trafermin, Recombinant human basic fibroblast growth factor | November 21, 2024 | 15ug | $198.00 |
|
| 1mg | $1,798.00 |
|
|||
| 5mg | $3,998.00 |
|
|||
| Add to Cart Online Order Request a Bulk Order | |||||
| Cat#: | THP-0292 |
| Product Name: | Trafermin, Recombinant human basic fibroblast growth factor |
| Cas No: | 131094-16-1 |
| Description: | Trafermin, also known as recombinant human basic fibroblast growth factor (rhbFGF), is a recombinant form of human basic fibroblast growth factor (bFGF) which is marketed in Japan as a topical spray for the treatment of skin ulcers. It is also currently in preregistration for the treatment of periodontitis. As a recombinant form of bFGF, trafermin is a potent agonist of the FGFR1, FGFR2, FGFR3, and FGFR4. The drug has been marketed in Japan since June 2001. |
| Species: | Human |
| Molecular Weight: | 17.122 kDa |
| Purity: | >99% by SDS-Page and HPLC analysis |
| Formula: | C764H1201N217O219S6 |
| Endotoxin: | <0.001 EU per 1 μg of the peptide by the LAL method |
| Application: | Investigated for use/treatment in coronary artery disease, peripheral vascular disease, periodontal disease, bone fractures, entero-related fistulae, and diabetic foot ulcers. |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.
